Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | 4-(2-Chloroethyl)morpholine | HCID 76727 | — |
| Reactant | HCID 20393030 | HCID 20393030 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 20393045 | HCID 20393045 | — |
Reaction Steps
A mixture consisting of 5.06 gm of 6,11-dihydro-2, 4,6-trimethyl-5H-pyrido[2,3-b][1,5]benzodiazepin-5-one, 1.1 gm of 50% sodium hydride in mineral oil and 60 ml of dimethyl formamide was stirred at 80° C. for 1 hour. Then, 4.5 gm of 2-morpholino-ethyl chloride were added, and the mixture was stirred at 120° C. for 3.5 hours more. The precipitate formed thereby was suction-filtered off, the solvent was removed from the filtrate in vacuo, and the oily residue was purified on a silica gel column. The product was recrystallized from petroleum ether (b.p. 100°-140° C.), yielding 64% of theory of the compound named in the heading, which had a melting point of 133°-135° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04167570 |
|---|
| Source dataset | uspto-grants-1979_09 |
|---|
| ORD ID | ord-3dc766cdb09041f09d72be4764c046c3 |
|---|
| Source note | uspto-grants-1979_09 |
|---|